Nevro Stock Falls 17%
Shares of Nevro Corp. (NVRO), a medical device company, are losing 17 percent on Tuesday morning trade. Analysts at Truist Financial Co. lowered the stock's target price from $32.
Source: rttnews.com
Page 11 - Senza Omnia News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Senza Omnia. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Senza Omnia Today - Breaking & Trending Today
Nevro Names New Chief Commercial Officer
Organizational Change Designed to Drive Strong Growth and Advance Global Commercial Focus Company Updates Second Quarter 2023 Revenue Guidance REDWOOD CITY, Calif., June 5, 2023 /PRNewswire/ --... | June 5, 2023
Source: marketscreener.com
Nevro Names New Chief Commercial Officer
/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...
Source: prnewswire.com
Nevro to Present at Jefferies Healthcare Conference
Thursday, June 8, 2023 at 10:30 am Eastern Time REDWOOD CITY, Calif., May 22, 2023 /PRNewswire/ -- Nevro Corp. , a global medical device company that is delivering comprehensive, life-changing... | May 22, 2023
Source: marketscreener.com
Nevro Reports First Quarter 2023 Financial Results, Provides Second Quarter Guidance and Reiterates Full-Year 2023 Guidance
/PRNewswire/ -- Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of...
Source: prnewswire.com